Question: Louisiana Subscriber Answer: What to do: If you bear the cost of the drug, you also should report A9543 (Yttrium Y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries). Note that A9543 is specific to therapeutic use. For diagnostic use, A9542 (Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries) would be the more appropriate code, paired, for example, with 78804 (Radiopharmaceutical localization of tumor or distribution of radiopharmaceutical agent[s]; whole body, requiring 2 or more days imaging). Check coverage policy: Strict payer guidelines often limit Zevalin coverage to patients who meet specific criteria, such as particular types of non-Hodgkin's lymphoma, certain platelet counts, and more.